We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+7.56%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$310B
AUM Growth
+$8.85B
Cap. Flow
-$12.9B
Cap. Flow %
-4.15%
Top 10 Hldgs %
14.55%
Holding
10,459
New
1,343
Increased
3,598
Reduced
4,167
Closed
928

Sector Composition

Rank Sector Weight
1 Technology 11.88%
2 Financials 7.38%
3 Consumer Discretionary 6.3%
4 Healthcare 6.09%
5 Communication Services 4.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IBA
5001
DELISTED
Industrias Bachoco SAB De C.V.
IBA
$339K ﹤0.01%
7,333
-3,435
-32% -$154K
SHG icon
5002
Shinhan Financial Group
SHG
$35.6B
$338K ﹤0.01%
9,451
+2,024
+27% +$72.7K
SVM
5003
Silvercorp Metals
SVM
$2.53B
$338K ﹤0.01%
61,569
-60,229
-49% -$350K
THER
5004
DELISTED
THERATECHNOLOGIES INC COM
THER
$338K ﹤0.01%
87,144
+12,043
+16% +$46.7K
ALT icon
5005
Altimmune
ALT
$599M
$337K ﹤0.01%
34,185
-57,642
-63% -$788K
HSTM icon
5006
HealthStream
HSTM
$840M
$337K ﹤0.01%
12,065
-10,482
-46% -$264K
GSBC icon
5007
Great Southern Bancorp
GSBC
$878M
$336K ﹤0.01%
6,233
-4,123
-40% -$231K
SSRM icon
5008
PUT
SSR Mining
SSRM
$6.48B
$335K ﹤0.01%
21,500
-4,500
-17% -$75.6K
GTHX
5009
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$335K ﹤0.01%
15,288
-51,183
-77% -$1.14M
ENDP
5010
DELISTED
Endo International plc
ENDP
$335K ﹤0.01%
71,595
-82,315
-53% -$472K
APOG icon
5011
Apogee Enterprises
APOG
$908M
$334K ﹤0.01%
8,194
-11,163
-58% -$421K
GOCO
5012
DELISTED
GoHealth
GOCO
$334K ﹤0.01%
1,983
-19
-0.9% -$3.33K
IGMS
5013
DELISTED
IGM Biosciences
IGMS
$333K ﹤0.01%
4,002
-12,259
-75% -$908K
TARO
5014
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
$333K ﹤0.01%
4,631
-761
-14% -$55.9K
DRN icon
5015
Direxion Daily Real Estate Bull 3X ETF
DRN
$44.8M
$331K ﹤0.01%
+15,395
New +$305K
SKINW
5016
DELISTED
The Beauty Health Company Warrant expiring 5/4/2026
SKINW
$331K ﹤0.01%
51,746
+1,746
+3% +$7.49K
AEVA
5017
Aeva Technologies
AEVA
$1.86B
$330K ﹤0.01%
6,229
-12,416
-67% -$627K
GPRK icon
5018
GeoPark
GPRK
$612M
$330K ﹤0.01%
26,129
-1,040
-4% -$15.9K
RL icon
5019
PUT
Ralph Lauren
RL
$23.6B
$330K ﹤0.01%
+2,800
New +$350K
QDYN
5020
DELISTED
FlexShares Quality Dividend Dynamic Index Fund
QDYN
$330K ﹤0.01%
5,534
-800
-13% -$47K
RBAC.U
5021
DELISTED
RedBall Acquisition Corp. Units, each consisting of one Class A ordinary share and one-third of one
RBAC.U
$329K ﹤0.01%
32,519
-615
-2% -$6.29K
VEDL
5022
DELISTED
Vedanta Limited American Depostary Shares (Each representing four equity shares)
VEDL
$329K ﹤0.01%
23,169
+6,611
+40% +$92.7K
ECF
5023
Ellsworth Growth & Income Fund
ECF
$172M
$326K ﹤0.01%
22,127
+577
+3% +$8.19K
MPX
5024
DELISTED
Marine Products Corp
MPX
$325K ﹤0.01%
21,083
+15,028
+248% +$250K
STKH
5025
Steakholder Foods
STKH
$1.11M
$325K ﹤0.01%
40
-5
-11% -$47K

Similar funds

UBS Group's Q2 2021 Portfolio in Review

As of Q2 2021, UBS Group held 10,459 positions worth $310B, up 2.9% from $301B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

UBS Group withdrew a net $12.9B in Q2 2021, closing 928 positions and reducing 4,167 holdings. Its most notable exit was INPHI CORPORATION, an estimated $121M position sold in full.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 11% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, UBS Group opened a new position in Dimensional US Core Equity 2 ETF worth $42.4M.

  • UBS Group's largest Q2 2021 buy was Dimensional US Core Equity 2 ETF: 1,571,036 shares worth $42.4M.
  • UBS Group added most to Just Eat Takeaway.com N.V. American Depositary Shares in Q2 2021, an estimated $1.02B increase.
  • UBS Group's biggest Q2 2021 reduction was Alibaba, cutting an estimated $2.65B.
  • UBS Group fully exited INPHI CORPORATION in Q2 2021, selling an estimated $121M.
  • UBS Group's ten largest holdings make up 15% of its $310B portfolio in Q2 2021.
  • UBS Group opened 1,343 new positions and closed 928 in Q2 2021.
  • UBS Group's portfolio value rose 2.9% quarter-over-quarter to $310B.

Based on UBS Group's 13F filing for Q2 2021, filed 13 Aug 2021.